CURRAX PHARMACEUTICALS
October 26, 2021
Press Releases
CURRAX PHARMACEUTICALS
October 21, 2021
Currax Pharmaceuticals Granted Type C Meeting with FDA Regarding its Phase 3 Study to Evaluate the Safety and Efficacy of CX-101
See moreCURRAX PHARMACEUTICALS
September 30, 2021
Currax Pharmaceuticals Hosted Ribbon-Cutting Ceremony to Mark the Opening of its Nashville Headquarters
See moreCURRAX PHARMACEUTICALS
August 2, 2021
Currax Pharmaceuticals Moves Global Headquarters to Brentwood, Tennessee
See moreCURRAXPHARMA
June 25, 2021
Currax Launches Why Weight: Communicate Initiative to Encourage Conversations about Weight Loss
See moreCURRAX PHARMACEUTICALS
February 27, 2020
Currax Pharmaceuticals Delivers Strong Operational and Financial Performance Eight Months into Operations
See moreCurrax™
May 1, 2019
Currax™ Holdings USA LLC Announces Launch and Close of Acquisition
See moreCurrax™ Pharmaceuticals LLC
September 27, 2019
Currax™ Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
See moreONZETRA® Xsail®
September 25, 2019